Having secured up to £26.7M of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis cultivation company, are delighted to announce...
Glass Pharms have agreed Heads of Terms with a leading infrastructure investment fund to provide up to £22.5m in financing to build the first dedicated medical...